In her presentation at CIO 2018, Dr. Brown reviewed the characteristics of the embolizing agents, the pre- and post-procedure protocols she follows, and other key tips for performing the procedure. | Read More
Percutaneous cryoblation ablation may be a reasonable treatment option for patients with clinical stage T1a papillary on renal cell carcinoma (pRCC) and clear-cell RCC (ccRCC), especially for patients with (pRCC). | Read More
The combination of microwave ablation and cementoplasty may offer patients with extra-spinal metastases a minimally invasive option for pain reduction | Read More
Researchers hypothesized that inhibition of cancer stem cells in HCC may improve the efficacy of percutaneous thermal ablation, TACE, and TAE. | Read More
Bradford Wood, MD, explains recent changes to the field of prostate cancer and how they may affect interventional oncologists. | Read More

Spotlight

In her presentation at CIO 2018, Dr. Brown reviewed the characteristics of the embolizing agents, the pre- and post-procedure protocols she follows, and other key tips for performing the procedure.
Bradford Wood, MD, explains recent changes to the field of prostate cancer and how they may affect interventional oncologists.
CIO included several featured abstracts, and we had the opportunity to talk in more detail with one of the authors.